Cannabis
TruTrace Technologies Appoints Deepak Anand as an Advisor
TruTrace Technologies Inc. (TSXV: TTT; OTC: BKKSF) (“TruTrace” or the “Company“) today announced Deepak Anand, CEO and Co-Founder of Materia Ventures, will become an advisor to the Company. Mr. Anand brings significant experience having worked closely with senior government officials, politicians, policy makers, health professional organizations, clinical practitioners, educators and investors. Mr. Anand can provide business development leadership and direction, particularly with respect to engagement with governmental bodies and regulatory agencies in jurisdictions in Canada, Europe and South America. Additionally, as Materia Ventures (“Materia“) continues to build out its infrastructure and technology assets across Europe, there will be opportunities for expanding the partnership and strategic opportunities between Materia and the Company.
Mr. Anand has held several roles of importance within the global cannabis sector. Currently, Mr. Anand is the CEO of Materia, a European-focused medical cannabis distribution and supply company. Deepak also has served on the boards of the Center for Medicinal Cannabis in the UK and he is also on the board of CFAMM (Canadians for Fair Access to Medical Marijuana) and the National Association of Cannabis Professionals.
“Mr. Anand’s prolific expertise liaising with government and other regulatory bodies in the cannabis industry is of great benefit to TruTrace Technologies,” said TruTrace Technologies CEO Robert Galarza. “As Deepak continues to build out the footprint for Materia throughout Europe, we see increasing opportunities for collaboration and partnership. Deepak’s valuable insights and established connections with a wide range of government and regulatory bodies will further enable us to develop and market our products with these critical agencies in mind.”
In connection with this appointment TruTrace has agreed to grant Mr. Anand stock options to acquire up to 150,000 common shares in the capital of TruTrace under the Company’s 2018 Stock Option Plan.
SOURCE TruTrace Technologies Inc
-
Innocan2 weeks ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis2 weeks ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis1 week ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis1 week ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE6 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis6 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis6 days ago
Rubicon Organics Reports Q1 2024 Financial Results